Erdenebaatar, C., Yamaguchi, M., Saito, F., Monsur, M., Honda, R., Tashiro, H., . . . Katabuchi, H. (2018). Administration of Cabergoline Contributes to Preserving Fertility in Young Hyperprolactinemic Patients With Endometrial Cancer Treated With Medroxyprogesterone Acetate. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 28(3), p. 539. doi:10.1097/IGC.0000000000001196
Chicago ZitierstilErdenebaatar, Chimeddulam, Munekage Yamaguchi, Fumitaka Saito, Mahina Monsur, Ritsuo Honda, Hironori Tashiro, Takashi Ohba, and Hidetaka Katabuchi. "Administration of Cabergoline Contributes to Preserving Fertility in Young Hyperprolactinemic Patients With Endometrial Cancer Treated With Medroxyprogesterone Acetate." International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 28, no. 3 (2018): 539.
MLA ZitierstilErdenebaatar, Chimeddulam, et al. "Administration of Cabergoline Contributes to Preserving Fertility in Young Hyperprolactinemic Patients With Endometrial Cancer Treated With Medroxyprogesterone Acetate." International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 28.3 (2018): 539.